DAFNA Capital Management LLC Buys Morphic Holding Inc, Revolution Medicines Inc, Protalix BioTherapeutics Inc, Sells Cassava Sciences Inc, Constellation Pharmaceuticals Inc, Neuronetics Inc

• New Purchases: PLX, ACET, RDHL, MRUS, IFRX, ASLN, ACAD, GMTX, COGT, BWAY, CBAY, KALV, INFI, CFMS, TPTX, RIGL, TBPH, SPPI, XFOR, NGM,
• Added Positions: MORF, RVMD, KRTX, MREO, ATHA, HOOK, KURA, MRSN, XENE, SNDX, PHAS, AFMD, HARP, BHVN, CGEN, LRMR, GNFT, RCUS, NTUS, ISEE, APLS,
• Reduced Positions: STIM, AGTC, FATE, NBIX, IBB, VRNA, SCYX, KNTE, PRQR, GLPG, VERO, KDMN, ATRC, AERI, ARAY, RDUS, MEIP, MDGL, VKTX, LCTX,
• Sold Out: SAVA, CNST, PRVL, FSDC, BLUE, PAND, BEAT,

For the details of DAFNA Capital Management LLC's stock buys and sells, go to https://www.gurufocus.com/guru/dafna+capital+management+llc/current-portfolio/portfolio

1. Stereotaxis Inc (STXS) - 13,680,554 shares, 22.78% of the total portfolio.
2. Fate Therapeutics Inc (FATE) - 314,360 shares, 6.42% of the total portfolio. Shares reduced by 5.98%
3. Blueprint Medicines Corp (BPMC) - 207,911 shares, 5.01% of the total portfolio. Shares added by 0.48%
4. Dicerna Pharmaceuticals Inc (DRNA) - 587,756 shares, 3.72% of the total portfolio.
5. Sage Therapeutics Inc (SAGE) - 181,306 shares, 3.36% of the total portfolio.

DAFNA Capital Management LLC initiated holding in Protalix BioTherapeutics Inc. The purchase prices were between $3.58 and $6.45, with an estimated average price of $4.66. The stock is now traded at around $2.890000. The impact to a portfolio due to this purchase was 1.33%. The holding were 1,204,825 shares as of 2021-03-31.

DAFNA Capital Management LLC initiated holding in Adicet Bio Inc. The purchase prices were between $12.12 and $17.17, with an estimated average price of $14.38. The stock is now traded at around $13.180000. The impact to a portfolio due to this purchase was 1.25%. The holding were 385,077 shares as of 2021-03-31.

DAFNA Capital Management LLC initiated holding in Redhill Biopharma Ltd. The purchase prices were between $6.98 and $11.29, with an estimated average price of $8.41. The stock is now traded at around $6.310000. The impact to a portfolio due to this purchase was 0.83%. The holding were 455,933 shares as of 2021-03-31.

DAFNA Capital Management LLC initiated holding in Merus NV. The purchase prices were between $16.14 and $29.11, with an estimated average price of $23.11. The stock is now traded at around $22.540000. The impact to a portfolio due to this purchase was 0.82%. The holding were 157,841 shares as of 2021-03-31.

DAFNA Capital Management LLC initiated holding in InflaRx NV. The purchase prices were between $3.62 and $6.34, with an estimated average price of $5.13. The stock is now traded at around $2.750000. The impact to a portfolio due to this purchase was 0.58%. The holding were 600,000 shares as of 2021-03-31.

DAFNA Capital Management LLC initiated holding in ASLAN Pharmaceuticals Ltd. The purchase prices were between $1.86 and $5.25, with an estimated average price of $3.17. The stock is now traded at around $2.750000. The impact to a portfolio due to this purchase was 0.56%. The holding were 677,500 shares as of 2021-03-31.

DAFNA Capital Management LLC added to a holding in Morphic Holding Inc by 195.23%. The purchase prices were between $29.77 and $84.85, with an estimated average price of $45.77. The stock is now traded at around $46.550000. The impact to a portfolio due to this purchase was 1.88%. The holding were 181,467 shares as of 2021-03-31.

DAFNA Capital Management LLC added to a holding in Revolution Medicines Inc by 572.14%. The purchase prices were between $37.21 and $54.43, with an estimated average price of $44.92. The stock is now traded at around $31.480000. The impact to a portfolio due to this purchase was 1.46%. The holding were 151,231 shares as of 2021-03-31.

DAFNA Capital Management LLC added to a holding in Karuna Therapeutics Inc by 187.98%. The purchase prices were between $95.46 and $133.08, with an estimated average price of $113.39. The stock is now traded at around $110.730000. The impact to a portfolio due to this purchase was 0.93%. The holding were 48,000 shares as of 2021-03-31.

DAFNA Capital Management LLC added to a holding in Mereo BioPharma Group PLC by 87.03%. The purchase prices were between $2.6 and $4.43, with an estimated average price of $3.53. The stock is now traded at around $2.940000. The impact to a portfolio due to this purchase was 0.48%. The holding were 1,249,648 shares as of 2021-03-31.

DAFNA Capital Management LLC added to a holding in Athira Pharma Inc by 453.69%. The purchase prices were between $16.9 and $29.77, with an estimated average price of $22.04. The stock is now traded at around $19.350000. The impact to a portfolio due to this purchase was 0.34%. The holding were 91,531 shares as of 2021-03-31.

DAFNA Capital Management LLC added to a holding in HOOKIPA Pharma Inc by 37.38%. The purchase prices were between $10.64 and $14.7, with an estimated average price of $12.06. The stock is now traded at around $18.080000. The impact to a portfolio due to this purchase was 0.31%. The holding were 343,455 shares as of 2021-03-31.

DAFNA Capital Management LLC sold out a holding in Cassava Sciences Inc. The sale prices were between $7.09 and $87.95, with an estimated average price of $39.44.

DAFNA Capital Management LLC sold out a holding in Constellation Pharmaceuticals Inc. The sale prices were between $23.39 and $37, with an estimated average price of $30.36.

DAFNA Capital Management LLC sold out a holding in Prevail Therapeutics Inc. The sale prices were between $22.91 and $23.2, with an estimated average price of $23.02.

DAFNA Capital Management LLC sold out a holding in FS Development Corp. The sale prices were between $11.32 and $13.5, with an estimated average price of $12.47.

DAFNA Capital Management LLC sold out a holding in bluebird bio Inc. The sale prices were between $25.62 and $52.33, with an estimated average price of $38.14.

DAFNA Capital Management LLC sold out a holding in Pandion Therapeutics Inc. The sale prices were between $17.1 and $61.63, with an estimated average price of $35.94.